Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 26.05%155.36M | 22.91%288.53M | --123.25M | 13.31%234.75M | 31.42%207.17M | 52.39%157.64M | 33.44%103.44M | --77.52M |
| Operating income | 26.05%155.36M | 22.91%288.53M | 123.25M | 13.31%234.75M | 31.42%207.17M | 52.39%157.64M | 33.44%103.44M | 77.52M |
| Cost of sales | 1.80%-47.39M | -51.94%-128.98M | ---48.26M | 18.29%-84.89M | -3.92%-103.88M | -65.07%-99.97M | -36.85%-60.56M | ---44.25M |
| Operating expenses | 1.80%-47.39M | -51.94%-128.98M | -48.26M | 18.29%-84.89M | -3.92%-103.88M | -65.07%-99.97M | -36.85%-60.56M | -44.25M |
| Gross profit | 43.98%107.96M | 6.46%159.55M | 74.99M | 45.09%149.86M | 79.09%103.29M | 34.48%57.67M | 28.90%42.89M | 33.27M |
| Selling expenses | -55.89%-9.18M | -73.52%-18.5M | ---5.89M | -66.39%-10.66M | -39.23%-6.41M | -72.78%-4.6M | -6.82%-2.66M | ---2.49M |
| Administrative expenses | -21.52%-24.2M | -15.55%-45.08M | ---19.91M | -32.04%-39.01M | -46.63%-29.54M | -96.93%-20.15M | -9.26%-10.23M | ---9.36M |
| Impairment and provision | -145.10%-7.64M | 104.91%365K | ---3.12M | -25.27%-7.44M | -535.76%-5.94M | 232.10%1.36M | -220.87%-1.03M | --853K |
| -Other impairment is provision | -145.10%-7.64M | 104.91%365K | ---3.12M | -25.27%-7.44M | -535.76%-5.94M | 232.10%1.36M | -220.87%-1.03M | --853K |
| Special items of operating profit | -69.57%364K | 176.19%8.92M | --1.2M | -170.18%-11.71M | 58.48%-4.33M | -983.57%-10.44M | 145.02%1.18M | --482K |
| Operating profit | 42.42%67.31M | 29.87%105.26M | 47.27M | 42.02%81.05M | 139.28%57.07M | -20.88%23.85M | 32.49%30.14M | 22.75M |
| Financing cost | 27.06%-2.31M | -123.82%-5.08M | ---3.17M | -55.87%-2.27M | -110.25%-1.46M | -50.00%-693K | -24.53%-462K | ---371K |
| Earning before tax | 47.41%65M | 27.16%100.18M | 44.1M | 41.66%78.78M | 140.15%55.61M | -21.98%23.16M | 32.63%29.68M | 22.38M |
| Tax | -37.64%-11.28M | -41.65%-19.54M | ---8.2M | -38.63%-13.8M | -112.54%-9.95M | 12.62%-4.68M | -36.75%-5.36M | ---3.92M |
| After-tax profit from continuing operations | 49.64%53.72M | 24.09%80.64M | 35.9M | 42.32%64.98M | 147.15%45.66M | -24.04%18.47M | 31.75%24.32M | 18.46M |
| Earning after tax | 49.64%53.72M | 24.09%80.64M | 35.9M | 42.32%64.98M | 147.15%45.66M | -24.04%18.47M | 31.75%24.32M | 18.46M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | 167.88%93K | ---137K |
| Profit attributable to shareholders | 49.64%53.72M | 24.09%80.64M | 35.9M | 42.32%64.98M | 147.15%45.66M | -23.75%18.47M | 30.28%24.23M | 18.6M |
| Basic earnings per share | 49.57%0.0697 | 6.84%0.1046 | 0.0466 | 38.47%0.0979 | 0.0707 | |||
| Diluted earnings per share | 49.57%0.0697 | 6.84%0.1046 | 0.0466 | 38.47%0.0979 | 0.0707 | |||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | Hong Kong Lixin Dehao Certified Public Accountants Limited | Hong Kong Lixin Dehao Certified Public Accountants Limited | Hong Kong Lixin Dehao Certified Public Accountants Limited | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.